Biomarkers in drug discovery and development

European Pharmaceutical Review

Volumn , Issue 5, 2010, Pages

  Seyhan, Attila A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIDIABETIC AGENT; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CA 125 ANTIGEN; CARBONATE DEHYDRATASE IX; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYSTATIN C; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBRONECTIN; FLUORODEOXYGLUCOSE; HEMOGLOBIN A1C; HLA B27 ANTIGEN; IMATINIB; IMIQUIMOD; INTERLEUKIN 2; MOLECULAR MARKER; TRANSCRIPTOME; TRASTUZUMAB; TROPONIN; VASCULOTROPIN;

AUTOIMMUNE DISEASE; BASAL CELL CARCINOMA; BREAST CANCER; COLORECTAL CANCER; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE COURSE; DRUG MARKETING; GENOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY CARCINOMA; MELANOMA; METABOLOMICS; METASTASIS; NEOPLASM; NONHUMAN; PATHOGENESIS; PHARMACOGENETICS; POSITRON; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROTEOMICS; REVIEW; RHEUMATOID ARTHRITIS; SAFETY; SJOEGREN SYNDROME; SURVIVAL; TRANSCRIPTOMICS; TREATMENT RESPONSE; VIRUS LOAD;

EID: 79952358571     PISSN: 13608606     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (53)

1. Butterfield, L. H. et al., (2008) J Transl Med 6, 81
2. Woosley, R. L. and Cossman, J., (2007) Clin Pharmacol Ther 81 (1), 129
3. Lang, L., (2004) Gastroenterology 127 (4), 1026
4. fda.gov, http://www.fda.gov/oc/speeches/ 2004/bascrty0707.html
5. Shendure, J., Mitra, R. D., Varma, C., and Church, G. M., (2004) Nat Rev Genet 5 (5), 335
6. Woodcock, J. and Woosley, R., (2008) Annu Rev Med 59, 1
7. Hughes, M. D. et al., (1998) AIDS 12 (14), 1823
8. Wagner, J. A., Williams, S. A., and Webster, C. J.,(2007) Clin Pharmacol Ther 81 (1), 104
9. D'Andrea, G. et al., (2005) Blood 105 (2), 645
10. Kirchheiner, J. and Brockmoller, J., (2005) Clin Pharmacol Ther 77 (1), 1 11.
11. Badagnani, I. et al., (2006) J Pharmacol Exp Ther 318 (2), 521 12.
12. Hung, S. I. et al., (2006) Pharmacogenet Genomics 16 (4), 297 13.
13. Buckland, D., (2010) The Bulletin Board 4 (3), 441 14.
14. Woodcock, J., (2007) Clin Pharmacol Ther 81 (2), 164 15.
15. Bayele, H. K. et al., (2010) Drug Discov Today 15 (3-4), 127 16.
16. Thomas, G. P. and Brown, M. A., (2010) Immunol Rev 233 (1), 162
17. de Vries, R. R., Huizinga, T. W., and Toes, R. E., (2005) J Autoimmun 25 Suppl, 21
18. Rifai, N., Gillette, M. A., and Carr, S. A., (2006) Nat Biotechnol 24 (8), 971
19. Group, T. B. D. W., (Clin. Pharmacol. Therap., 2001), Vol. 69, pp. 89
20. Alevizos, I. and Illei, G. G., (2010) Nat Rev Rheumatol 6 (7), 391
21. Administration, U. S. F. a. D., edited by U. S. D. o. H. a. H. S. U.S. Food and Drug Administration (Rockville, MD, USA, March 2004)
22. Lee, J. W. et al., (2006) Pharm Res 23 (2), 312
23. Erler, J. T. and Linding, R., (2010) J Pathol 220 (2), 290
24. Ong, S. E. and Mann, M., (2005) Nat Chem Biol 1 (5), 252
25. Kotz, K. T. et al., (2010) Nat Med 16 (9), 1042 26.
26. Haining, W. N. and Wherry, E. J., (2010) Immunity 32 (2), 152
27. Heng, T. S. and Painter, M. W., (2008) Nat Immunol 9 (10), 1091
28. Hyatt, G. et al., (2006) Nat Immunol 7 (7), 686
29. Schones, D. E. et al., (2008) Cell 132 (5), 887
30. Wu, H. et al., (2007) PLoS One 2 (10), e1020
31. Araki, Y. et al., (2009) Immunity 30 (6), 912 32.
32. Fathman, C. G., Soares, L., Chan, S. M., and Utz, P. J., (2005) Nature 435 (7042), 605
33. Drynda, S. et al., (2004) Pathol Res Pract 200 (2), 165
34. Gramolini, A. O., Peterman, S. M., and Kislinger, T., (2008) Clin Pharmacol Ther 83 (5), 758
35. Rolan, P., (1997) Br J Clin Pharmacol 44 (3), 219 36.
36. Nevins, J. R. and Potti, A., (2007) Nat Rev Genet 8 (8), 601
37. Vitzthum, F., Behrens, F., Anderson, N. L., and Shaw, J. H., (2005) J Proteome Res 4 (4), 1086
38. Caux, C., Roy, D. J., Guilbert, L., and Viau, C., (2007) Soc Sci Med 65 (2), 344
39. Singh, I. and Rose, N., (2009) Nature 460 (7252), 202
40. Dumez, B., Van Damme, K., and Casteleyn, L., (2007) Int J Hyg Environ Health 210 (3-4), 263
41. Sabatino, M. et al., (2009) J Clin Oncol 27 (16), 2645
42. Atkins, M. et al., (2005) Clin Cancer Res 11 (10), 3714
43. Nishimura, K. et al., (2007) Ann Intern Med 146 (11), 797
44. Schulte-Pelkum, J., Fritzler, M., and Mahler, M., (2009) Autoimmun Rev 8 (7), 632
45. Galon, J. et al., (2006) Science 313 (5795), 1960
46. Zhang, L. et al., (2003) N Engl J Med 348 (3), 203
47. Panelli, M. C. et al., (2007) Genome Biol 8 (1), R8
48. Winkler, H., (2010) European Pharmaceutical Review (Volume 13, Issue 3)
49. Eck, S. L. and Paul, S. M., (2009) Clin Pharmacol Ther 87 (1), 21
50. Wagner, J. A. et al., (2009) Clin Pharmacol Ther 86 (6), 619
51. Holmgren, E., (2008) Stat Med 27 (24), 4928
52. Zwierzina, H., (2008) Ann Oncol 19 Suppl 5, v33
53. Sistare, F. D. et al., (2010) Nat Biotechnol 28 (5), 446